Website stats and analysis

About ProgenicsProgenics develops innovative medicines and other technologies to target and treat cancer, including: therapeutic agents designed to treat cancer (AZEDRA, , and PSMA TTC); prostate-specific membrane antigen (“PSMA”) targeted imaging agents for prostate cancer (PyL); and imaging analysis technology (aBSI and PSMA AI). Progenics has two commercial products, AZEDRA, for the treat...

2.48 Rating by Usitestat

progenics.com was registered 2 decades 6 years ago. It has a alexa rank of #3,089,638 in the world. It is a domain having .com extension. It is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently, progenics.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 284
Daily Pageviews: 568

Estimated Valuation

Income Per Day: $ 2.00
Estimated Worth: $ 480.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 3,089,638
PageSpeed Score: 58 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

96.125.169.163

Hosted Country:

United States US

Location Latitude:

29.8312

Location Longitude:

-95.4741

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For progenics.com

Progenics Pharmaceuticals | Developing Innovative Cancer ...

- https://www.progenics.com/

About Progenics. Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight...


Progenics (@Progenics) • Twitter

- https://twitter.com/Progenics

We would like to show you a description here but the site won’t allow us.


Progenics Pharmaceuticals Inc. (PGNX) Company Profile ...

- https://finance.yahoo.com/quote/PGNX/profile

See the company profile for Progenics Pharmaceuticals Inc. (PGNX) including business summary, industry/sector information, number of employees, business summary, corporate...


Progenics Pharmaceuticals, Inc. | LinkedIn

- https://www.linkedin.com/company/progenics-pharmaceuticals

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development....


Progenics Pharmaceuticals Inc - Company Profile and News ...

- https://www.bloomberg.com/profile/company/PGNX:US

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with...


Progenics Stockholders Approve Merger with Lantheus Nasdaq ...

- https://www.globenewswire.com/news-release/2020/06/16/2049136/0/en/Progenics-Stockholders-Approve-Merger-with-Lantheus.html

Jun 16, 2020 · NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) (“Progenics”), an oncology company developing innovative medicines and …


Lantheus to Acquire Progenics to Form a Leading Precision ...

- https://www.businesswire.com/news/home/20191002005444/en/Lantheus-Acquire-Progenics-Form-Leading-Precision-Diagnostics

Oct 02, 2019 · Lantheus Holdings Investor Contact: Mark Kinarney 978-671-8001 [email protected] Media Contacts: Meara Murphy 978-671-8508 [email protected] Sard Verbinnen...


Progenics Announces $50 Million RELISTOR® Royalty-Backed ...

- https://www.healthcareroyalty.com/progenics-announces-50-million-relistor-royalty-backed-financing/

Provides Non-Dilutive Funding to Advance Late-Stage Oncology Portfolio. NEW YORK, Nov. 07, 2016 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology...


AZEDRA

- https://www.azedra.com/

This is a rare moment. AZEDRA is a prescription medicine used to treat adult and pediatric patients 12 years and older with cancers known as pheochromocytoma and paraganglioma...


Progenics Pharmaceuticals, Inc. Company Information ...

- https://www.drugs.com/manufacturer/progenics-pharmaceuticals-inc-117.html

Progenics Pharmaceuticals, Inc. manufactures, markets and/or distributes 1 drug in the U.S.


Progenics Pharmaceuticals - Crunchbase Company Profile ...

- https://www.crunchbase.com/organization/progenics-pharmaceuticals-inc

Contact Email [email protected] Phone Number 9147892800 Progenics Pharmaceuticals, Inc., of Tarrytown, N.Y., is a biopharmaceutical company focused on innovative therapeutics...


Progenics Pharmaceuticals - Overview, News & Competitors ...

- https://www.zoominfo.com/c/Progenics-pharmaceuticals-inc/31408343

View Progenics Pharmaceuticals (www.progenics.com) location in New York, United States , revenue, industry and description. Find related and similar companies as …


Progenics Pharmaceuticals Sets First Quarter 2020 ...

- https://finance.yahoo.com/news/progenics-pharmaceuticals-sets-first-quarter-123010416.html

A live webcast will be available in the Media Center of the Progenics website, www.progenics.com, and a replay will be available there for two weeks. Progenics is an oncology...


Progenics Pharmaceuticals, Inc. - MPR

- https://www.empr.com/manufacture/progenics-pharmaceuticals-inc/

Please login or register first to view this content. Back to Top Resources


Progenics Highlights Additional Serious Concerns About ...

- https://www.marketwatch.com/press-release/progenics-highlights-additional-serious-concerns-about-velan-capital-lp-2019-10-23

Oct 23, 2019 · Investor Contact Melissa Downs Investor Relations (646) 975-2533 [email protected] Additional Investor Contact Bob Marese / David Whissel MacKenzie Partners,...


Progenics Pharmaceuticals Inc. (PGNX) Stock Message Board ...

- https://investorshub.advfn.com/Progenics-Pharmaceuticals-Inc-PGNX-12133/

Feb 26, 2020 · Company Name: Progenics Pharmaceuticals Inc., Stock Symbol: PGNX, Industry: Biotechs, Total Posts: 796, Last Post: 2/26/2020 10:58:15 PM


Progenics Stockholders Approve Merger with Lantheus ...

- https://www.marketwatch.com/press-release/progenics-stockholders-approve-merger-with-lantheus-2020-06-16

Jun 16, 2020 · The MarketWatch News Department was not involved in the creation of this content. NEW YORK, June 16, Jun 16, 2020 (GLOBE NEWSWIRE via COMTEX) -- Progenics...


Progenics Pharmaceuticals Inc (PGNX) 10K Annual Reports ...

- https://last10k.com/sec-filings/pgnx

Mar 13, 2020 · Progenics Pharmaceuticals, Inc. One World Trade Center. 47 th Floor, Suite J. New York, New York 10007 (646) 975-2500. www.progenics.com


Progenics to Mail Letter to Shareholders Nasdaq:PGNX

- https://www.globenewswire.com/news-release/2019/06/13/1868719/0/en/Progenics-to-Mail-Letter-to-Shareholders.html

Jun 13, 2019 · [email protected]. Additional Investor Contact Bob Marese / David Whissel MacKenzie Partners, Inc. (212) 929-5500. Media Contact Michael Freitag / James Golden...


Progenics Pharmaceuticals Inc Company Profile | New York ...

- https://www.dnb.com/business-directory/company-profiles.progenics_pharmaceuticals_inc.5141005d8f5b21796337f78408e1a238.html

Find company research, competitor information, contact details & financial data for Progenics Pharmaceuticals Inc of New York, NY. Get the latest business insights from Dun &...


Leading Independent Proxy Advisory Firm Glass Lewis ...

- https://markets.businessinsider.com/news/stocks/leading-independent-proxy-advisory-firm-glass-lewis-recommends-progenics-shareholders-vote-for-all-of-progenics-director-nominees-1028320710

Jul 01, 2019 · [email protected]. Additional Investor Contact Bob Marese / David Whissel MacKenzie Partners, Inc. (212) 929-5500. Media Contact Michael Freitag / James Golden...

Page Resources Breakdown

Homepage Links Analysis

Progenics Pharmaceuticals | Developing Innovative Cancer Therapies
Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic technologies.

Website Inpage Analysis

H1 Headings: Not Applicable H2 Headings: 3
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 3
Google Adsense: Not Applicable Google Analytics: UA-41834475-1

Mobile Friendly Check


Mobile Friendly : Unknown
Score : Unknown

No data to show.

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Wed, 10 Jul 2019 02:10:31 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel=shortlink
X-UA-Compatible: IE=edge,chrome=1
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8

Domain Information

Domain Registrar: Network Solutions, LLC
Registration Date: 1997-11-09 2 decades 6 years 7 months ago
Last Modified: 2016-07-17 7 years 11 months 2 weeks ago

Domain Nameserver Information

Host IP Address Country
ns1.hvdata.net 64.72.64.10 United States United States
ns2.hvdata.net 72.22.160.14 United States United States

DNS Record Analysis

Host Type TTL Extra
progenics.com A 2504 IP: 96.125.169.163
progenics.com NS 1370 Target: ns1.hvdata.net
progenics.com NS 3600 Target: ns2.hvdata.net
progenics.com SOA 3600 MNAME: ns1.hvdata.net
RNAME: ns-admin.hvdata.net
Serial: 2019061801
Refresh: 3600
Retry: 600
Expire: 86400
progenics.com MX 949 Target: progenics-com.mail.protection.outlook.com
progenics.com MX 3600 Priority: 20
Target: progenics-com.mail.eo.outlook.com
progenics.com TXT 3600 TXT: v=spf1 mx ip4:206.200.251.19
mx:progenics-com.mail.eo.outlook.com
include:spf.protection.outlook.com
include:mail.zendesk.com
include:servers.mcsv.net ~all
progenics.com TXT 3600 TXT:
adobe-sign-verification=ca852fe1d72ba988
4b61775ab5a5d8e5
progenics.com TXT 3600 TXT:
adobe-idp-site-verification=616cd3ed8d43
f4f64b210b9058ff367bcc46da06f5640823d791
2574b2f108e4

Alexa Traffic Rank

Alexa Search Engine Traffic

Full WHOIS Lookup

Domain Name: PROGENICS.COM
Registry Domain ID:
616797_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.networksolutions.com
Registrar URL:
http://networksolutions.com
Updated Date:
2016-07-16T21:59:29Z
Creation Date:
1997-11-09T05:00:00Z
Registry Expiry Date:
2019-11-08T05:00:00Z
Registrar: Network Solutions,
LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.HVDATA.NET
Name Server: NS2.HVDATA.NET
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2019-07-10T02:11:31Z

Similarly Ranked Websites

Prawo Dla Każdego

- prawodlakazdego.pl

3,089,650   $ 480.00

Games4pro - Get Latest Information Of Gaming Feild

- games-4pro.com

Games4pro - Get Latest News Of Gaming Feild, All video game news, All Reviews, and walkthroughs for xbox 360, xbox one, ps3, ps4, PC, Vita Here.

3,089,681   $ 480.00


MPPT Solar Charge Controller, Off Grid Inverter, On Grid Inverter -...

- fangpusun.com

Wenzhou Xihe Electric Co.,Ltd, China solar charge controler, off grid inverter, on grid inverter MPPT Solar charge controller manufacturer and supplier. Welcome to contact us.

3,089,739   $ 480.00

Extra Speed Delivery & Logistics

- exsldelivery.eu

3,089,762   $ 480.00